Patents by Inventor Margaret Lorraine Dunkley

Margaret Lorraine Dunkley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NON-TYPEABLE HAEMOPHILUS INFLUENZAE VACCINES AND THEIR USES
    Publication number: 20180125963
    Abstract: Provided are non-typeable Haemophilus influenzae vaccines useful for the treatment of chronic obstructive pulmonary disease and asthma in a patient. In certain aspects, the vaccine is a monobacterial vaccine. Bacterial strains for use in the vaccines of the present application are also provided.
    Type: Application
    Filed: January 8, 2018
    Publication date: May 10, 2018
    Inventors: MARGARET LORRAINE DUNKLEY, ROBERT LLEWELLYN CLANCY
  • Non-typeable vaccines and their uses
    Patent number: 9943584
    Abstract: Provided are non-typeable Haemophilus influenzae vaccines useful for the treatment of chronic obstructive pulmonary disease and asthma in a patient. In certain aspects, the vaccine is a monobacterial vaccine. Bacterial strains for use in the vaccines of the present application are also provided.
    Type: Grant
    Filed: September 17, 2009
    Date of Patent: April 17, 2018
    Assignee: HUNTER IMMUNOLOGY LIMITED
    Inventors: Margaret Lorraine Dunkley, Robert Llewellyn Clancy
  • Compositions and methods for treatment of mucosal infections
    Patent number: 8637051
    Abstract: The present invention is concerned with novel compositions and vaccines useful for prophylactic an/or therapeutic treatment of mucosal infections, and in particular it is concerned with oral vaccines and with methods of enhancing mucosal resistance to infection or for treating established infections, of the respiratory tract.
    Type: Grant
    Filed: May 21, 2001
    Date of Patent: January 28, 2014
    Assignee: Hunter Immunology Limited
    Inventors: Robert Llewellyn Clancy, Gerald Pang, Margaret Lorraine Dunkley
  • Non-Typeable Haemophilus Influenzae Vaccines and Their Uses
    Publication number: 20110206765
    Abstract: Provided are non-typeable Haemophilus influenzae vaccines useful for the treatment of chronic obstructive pulmonary disease and asthma in a patient. In certain aspects, the vaccine is a monobacterial vaccine. Bacterial strains for use in the vaccines of the present application are also provided.
    Type: Application
    Filed: September 17, 2009
    Publication date: August 25, 2011
    Applicant: Hunter Immunology Limited
    Inventors: Margaret Lorraine Dunkley, Robert Llewellyn Clancy
  • Compositions and methods for treatment of mucosal infections
    Publication number: 20040057965
    Abstract: The present invention is concerned with novel compositions and vaccines useful for prophylactic an/or therapeutic treatment of mucosal infections, and in particular it is concerned with oral vaccines and with methods of enhancing mucosal resistance to infection or for treating established infections, of the respiratory tract.
    Type: Application
    Filed: May 22, 2003
    Publication date: March 25, 2004
    Inventors: Robert Llewellyn Clancy, Gerald Pang, Margaret Lorraine Dunkley
  • Treating endotoxemia and related disorders with probiotics
    Publication number: 20040047868
    Abstract: The invention relates to methods of preventing and treating endotoxemia and related disorders. In particular, the invention relates to methods of preventing and treating endotoxemia and related disorders using a probiotic. The invention also relates to methods for assessing the efficacy ot a probiotic in the prevention and treatment of endotoxemia and related disorders.
    Type: Application
    Filed: July 31, 2003
    Publication date: March 11, 2004
    Inventors: Gerald Pang, John Cade, Robert Llewellyn Clancy, Robert Batey, Margaret Lorraine Dunkley, Patricia Lynne Conway
  • Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor
    Publication number: 20030180260
    Abstract: Compositions and methods for therapeutic or prophylactic treatment of disorders associated with mucosal surfaces and in particular to treatment of infectious disorders at mucosal sites by enhancing non-specific mucosal immunity, especially with probiotics such as lactobacillus or mycobacterium vaccae.
    Type: Application
    Filed: May 9, 2003
    Publication date: September 25, 2003
    Inventors: Robert Llewellyn Clancy, Gerald Pang, Thomas Julius Borody, Margaret Lorraine Dunkley, Patricia Lynne Conway
  • Oral vaccine comprising antigen surface-associated with red blood cells
    Patent number: 5882649
    Abstract: Red blood cells or derivatives thereof such as ghost preparations, whole cell membrane preparations or fragments thereof, can act as a potent carrier for orally administered antigens. Mucosal immunity in particular can be effectively induced against such viruses as influenza when adsorbed to chicken red blood cells and orally administered.
    Type: Grant
    Filed: January 6, 1997
    Date of Patent: March 16, 1999
    Assignee: Flustat Pty. Ltd.
    Inventors: Gerald Toh Pang, Robert Llewellyn Clancy, Allan William Cripps, Margaret Lorraine Dunkley